Article citationsMore>>

Chetcha, C.B., Ola’a, B.E.K., Ngo, S.F., Ngouadjeu, E. and Mbanya, D. (2018) Morbidity and Mortality among Patients Sickle Cell at the Service Department of Hematology of the Central Hospital of Yaoundé. Health Sciences, 19, 71-75.

has been cited by the following article:

• TITLE: Evaluation of the Quality of Care Children Sickle Cell from 0 to 15 Years Old in the Pediatrics Department of the Ignace Deen University Hospital in Conakry

  AUTHORS: Diakité Mamady, Traoré Moussa, Condé AAbdoulaye, Doukouré Aboubacar Sidiki, Cissé Mohamed Yamine, Condé Mamadi Sadan, Camara Amadou Sekou, Diallo Abdoul Goudousy, Kouyaté Fodé, Dambakaté Alhassane, Kanté Ansoumane Sayon, Camara Emmanuel

  KEYWORDS: Evaluation, Management, Sickle Cell Disease, Pediatrics, Conakry

  JOURNAL NAME: Open Journal of Pediatrics, Vol.16 No.3, May 28, 2026

  ABSTRACT: Introduction: Sickle cell disease is a chronic disease primarily affecting the black population, associated with significant morbidity and mortality. The aim of this work is to evaluate the quality of care provided. Children sickle cell from 0 to 15 years old in the Pediatrics department of the Ignace Deen University Hospital in Conakry. Materials and methods: We conducted a descriptive cross-sectional study of a duration of 6 month from December 15, 2020 to May 14 2021. Results: The average age of the patients was 6.38 ± 4.02 years with a sex ratio of 0.69. Abdominal examinations of children with sickle cell disease At service of Pediatric cases were characterized by: fever (100%), severe anemia (52.46%), physical asthenia (54.10%), abdominal pain (42.62%), and jaundice (40.98%). The predominance of school-aged children (63.93%), the majority of patients residing in the main town (80.33%), and a history of consanguinity (52%) were also noted. The predominant first-line treatment was: Hyperhydration and analgesics (100%), antibiotics (96.72%), and blood transfusion (80.33%). The level of technical competence found was good (63.64%); acceptable (18.18%); and poor (18.18%). Conclusion: This study shows that the quality of care for sickle cell disease in children is complex and medically sound and acceptable. However, the human and infrastructural aspects need strengthening, implying the need for subsidies to cover the costs of examinations and treatments for children with sickle cell disease.